F. Gremy et Lr. Salmi, PREDICTIVE VALUES OF USUAL BIOLOGIC TESTS FOR DETECTION OF HIV - CONSEQUENCES FOR SCREENING, Bulletin de l'Academie nationale de medecine, 179(2), 1995, pp. 317-333
This paper tries to review what is scientifically known about the pred
ictive values of biological tests of HIV infection. The epidemiologica
l situation for that infection is characterized by two facts : the ver
y high values of sensitivity and specificity which are close to unity;
the prevalence of seropositivity which is on average - at least in we
stern countries -, very low (except for some small specific groups). U
nder those conditions, Negative Predictive Values are always very clos
e to unity, and the percentage of false negative tests is extremely lo
w. Things are quite different for Positive Predictive Value, which var
ies very rapidly with very small shifts or uncertainties about specifi
city and prevalence. In the case when prevalence is very low (general
population screening) and at the same time specificity is not excellen
t (that means < 0,99 or even < 0,995), Positive Predictive Value is ve
ry poor and the proportion of false positive tests rather important. I
ndeed the analysis of scientific literature, using the method of <<bes
t synthesis evidence>>, reveals numerous discrepancies as to the value
of specificity among different tests. Figures vary a lot from one stu
dy to another. It is not obvious which screening strategies are concer
ned by the results, which finally entail a strong statistical uncertai
nty. Finally, the figures published in the literature are given by hig
h standard laboratories. One may fear the tests realized in routine la
boratories are less reliable. As a conclusion, let us say that despite
their very good quality, the biological tests, when used separately,
should not be trusted without strong previous criticism when applied t
o samples of the general population. Any biological screening should b
e preceded by a clinical examination, including a precise inquiry, in
order to detect people at risk, that means with a high prior probabili
ty. Clinical dialogue has moreover another great interest : it allows
health consulting and education, and calls for personal responsibility
for both seropositive and negative subjects. It is the best choice of
method to reach a high preventive effectiveness.